LSE:ERGO (Ergomed plc)

About ERGO

Ergomed PLC is engaged in the healthcare sector. Its business involves the provision of drug development services to the pharmaceutical industry. The company operates through two segments: Clinical Research Outsourcing and Pharmacovigilance. It provides clinical development services to clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. The PV segment has expertise in the field of pharmacovigilance and provides medical information services.
  • Ergomed plc (LSE: ERGO) Latest News

    Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo
    Page

    Investing in Genetics: Top UK Genetics Stocks in 2022

    Investing in genetics stocks is a risky endeavour. But given industry specialists have and continue to describe this space as…

    Read more »

    Investing Articles

    How I’d look to turn a £1,000 investment in UK growth shares into £5,000

    There are UK growth shares in both the FTSE and AIM markets, contrary to the view of some investors that…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    2 UK biotech stocks to watch in 2021

    Combined, these two biotech stocks are up 100% over the last 12 months! Zaven Boyrazian takes a closer look at…

    Read more »

    Investing Articles

    Alongside AstraZeneca, I’d buy this small-cap share in the pharmaceutical sector

    AstraZeneca’s R&D pipeline is producing new treatments, while this cash-rich small-cap is engaged in studies aimed at treating the symptoms…

    Read more »

    Investing Articles

    AstraZeneca and this small growth pharma stock could make you brilliantly rich

    Harvey Jones finds a racy little pharma stock to sit beside dividend and growth monster AstraZeneca plc (LON: AZN) in…

    Read more »

    Investing Articles

    GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement

    This company could generate high returns alongside GlaxoSmithKline plc (LON:GSK) (GSK.L).

    Read more »

    Investing Articles

    A small-cap growth stock I’d buy alongside Premier Oil plc in 2018

    Premier Oil plc (LON: PMO) could finally be on the up, and here's another potential growth winner I'd buy too.

    Read more »

    Investing Articles

    These small-cap growth stocks could be millionaire-makers

    I think these two growers look set to advance further.

    Read more »